Clinical Trials Logo

Clinical Trial Summary

Describe the incidence of metabolic disorders in neonatal convulsions affecting neonates at NICU Describe types of metabolic disorders causing neonatal convulsions


Clinical Trial Description

Neonates are susceptible to seizures due to several physiologic factors and combination of risks that are uniquely associated with gestation, delivery,and the immediate postnatal period. Neonatal seizures can be challenging to identify therefore itis imperative that clinicians have ahigh degree of suspicion for seizures based on the clinical history or the presence of encephalopathy with or without paroxysmal abnormal movements. Acute symptomatic neonatal seizures are due to an acute brain injury, whereas neonatal onset_epilepsy may be due to underlying structural, metabolic ,or genetic disorders.Early identification and treatment are likely important for long term outcomes in acute symptomatic seizures though additional studies are needed to understand optimal seizure control metrics and the ideal duration of treatment. seizures may be the first and the major presenting feature of an inborn error of metabolism. seizures may be preceded by other major symptoms by areduced level of consciousness in achild with an organic acidemia or urea cycle defect or by loss of skills ,progressive weakness ,ataxia ,and upper motor signs in achild with lysosomal storage disorder or peroxisomal leukodystrophy.the metabolic causes of seizure vary according to age at presentation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06108778
Study type Observational
Source Assiut University
Contact Amira Mohamed Sayed, master
Phone 01140282846
Email amiramohamed12yahoo@gmail.com
Status Not yet recruiting
Phase
Start date November 25, 2023
Completion date February 25, 2025

See also
  Status Clinical Trial Phase
Completed NCT03071783 - Intra-operative Feed Back on Traction Force During Vacuum Extraction: Safe Vacuum Extraction Alliance N/A